Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOG-0262: Paclitaxel and Carboplatin With or Without Bevacizumab in Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT01167712Phase 3Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Sep 2010
- Primary completion
- Dec 2015
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection in ovarian cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by National Cancer Institute. Started Sep 2010; status: active, not recruiting.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT01167712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01167712.